Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Top Stock Reports for Exxon Mobil, Eli Lilly & Costco

Published 07/19/2021, 01:45 AM
Updated 07/09/2023, 06:31 AM

Monday, July 19, 2021

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil (XOM), Eli Lilly (LLY), and Costco Wholesale (COST). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Exxon Mobil have outperformed the Zacks Integrated International Oil industry over the past year (+39.2% vs. +29.1%), reflecting major discoveries in the Stabroek Block have enhanced prospects for ExxonMobil's upstream businesses.

The firm also has a strong presence in the prolific Permian where it continues to lower its fracking & drilling costs. The company projects annual structural expense savings of $6 billion by 2023, which is likely to aid its bottom line. ExxonMobil also has a strong balance sheet. ExxonMobil's bellwether status and an optimal integrated capital structure make it a relatively lower-risk energy stock to own.

(You can read the full research report on Exxon Mobil here >>>)

Eli Lilly shares have gained +16.1% over the last six months against the Zacks Large Cap Pharmaceuticals industry’s gain of 8%. The Zacks analyst believes that higher demand for drugs like Trulicity and Taltz, among others has been driving Lilly’s revenue growth.

Lilly has an impressive pipeline including that for cancer, diabetes and Alzheimer's. This is expected to boost its growth potential beyond 2025. Generic competition for several drugs, rising pricing pressure in the United States, as well as price cuts in international markets like China, Japan and Europe are some top-line headwinds.

(You can read the full research report on Eli Lilly here >>>)

Shares of Costco have gained +11% in the past three months against the Zacks Discount Retail industry’s gain of +6.7%. The Zacks analyst believes that the company has been benefiting from its growth strategies, better price management, decent membership trend and increasing penetration of the e-commerce business.

The strategy to sell products at discounted prices has helped attract customers seeking both value and convenience. Mass inoculation drive as well as the stimulus package have encouraged spending across the board. In the third-quarter fiscal 2021, the company maintained its stellar comps run.

(You can read the full research report on Costco here >>>)

Other noteworthy reports we are featuring today include Ecolab (ECL), Aon plc (NYSE:AON) (AON) and EOG Resources (NYSE:EOG) (EOG).

Sheraz Mian

Director of Research

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>


5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ecolab Inc. (NYSE:ECL): Free Stock Analysis Report

Exxon Mobil Corporation (NYSE:XOM): Free Stock Analysis Report

Eli Lilly and Company (NYSE:LLY): Free Stock Analysis Report

EOG Resources, Inc. (EOG): Free Stock Analysis Report

Costco Wholesale Corporation (NASDAQ:COST): Free Stock Analysis Report

Aon plc (AON): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.